The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.

Erhabor, O; Ejele, O A; Nwauche, C A

Erhabor, O; Ejele, O A; Nwauche, C A.

Affiliation

Erhabor O; Department of Hematology University of Port Harcourt Teaching Hospital, P.M.B. 6173, Port Harcourt, Nigeria. osaro@yahoo.com

Niger J Clin Pract ; 9(2): 128-33, 2006 Dec.

Article in En | MEDLINE | ID: mdl-17319344

Subject(s)

Anti-Retroviral Agents/therapeutic use; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; HIV Infections/drug therapy; Lamivudine/therapeutic use; Nevirapine/therapeutic use; Stavudine/therapeutic use; Treatment Outcome; Adult; Case-Control Studies; Female; Humans; Male; Middle Aged; Nigeria; Prognosis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Treatment Outcome / Stavudine / CD4 Lymphocyte Count / Lamivudine / Nevirapine / Antiretroviral Therapy, Highly Active / Anti-Retroviral Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Niger J Clin Pract Journal subject: MEDICINA Year: 2006 Type: Article Affiliation country: Nigeria

Search on Google

XML

PubMed Links